Search
European Commission's (HTACG): General Principles for Using Artificial Intelligence in the Preparation of Joint Clinical Assessments Dossiers
Artificial Intelligence (AI) is increasingly being explored across evidence generation, analysis, and reporting, offering opportunities to improve the efficiency of processes supporting health technology assessment. However, when AI is used to prepare evidence for regulatory and assessment purposes, its potential benefits must be balanced against risks to completeness, methodological quality, scientific rigour, and reliability. To address these considerations, the Member Stat
Sharan Murugan
Jul 203 min read
Meet ELSA: USFDA Launches Agency-Wide AI Tool to Optimize Performance
What if the agonizing wait for drug approvals could be slashed from days to minutes? Imagine a future where breakthrough therapies reach...
Sharan Murugan
Jun 2, 20252 min read